Cargando…
Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
The optimal treatment of recurrent glioblastoma (GBM) remains controversial. Therefore, our study aimed to compare and rank active therapies in recurrent GBM. We performed a systematic review and a Bayesian network meta-analysis. We obtained a treatment hierarchy using the surface under the cumulati...
Autores principales: | Chen, Wenlin, Wang, Yuekun, Zhao, Binghao, Liu, Penghao, Liu, Lei, Wang, Yu, Ma, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039381/ https://www.ncbi.nlm.nih.gov/pubmed/33854975 http://dx.doi.org/10.3389/fonc.2021.641878 |
Ejemplares similares
-
Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation
por: Lei, Chuxiang, et al.
Publicado: (2021) -
Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma
por: Zhao, Binghao, et al.
Publicado: (2023) -
Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses
por: Zhao, Binghao, et al.
Publicado: (2020) -
NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
por: Wang, Yuekun, et al.
Publicado: (2020) -
Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials
por: Chen, Wenlin, et al.
Publicado: (2021)